Source:http://linkedlifedata.com/resource/pubmed/id/14500352
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
17
|
pubmed:dateCreated |
2003-9-22
|
pubmed:abstractText |
Biological and epidemiological data suggest that progesterone has an important role in mammary tumorigenesis. Because the effects of progesterone require the progesterone receptor (PGR), which exists in two isoforms, PR-A and PR-B, we sought to determine whether the functional polymorphism, +331 G/A, which causes an increase in the expression of the hPR-B isoform, is related to breast cancer risk. Using a nested case-control study design within the Nurses' Health Study cohort, we genotyped 990 cases and 1,364 controls and observed a statistically significant increased risk of breast cancer among carriers of the +331 A allele (odds ratio, 1.33; 95% confidence interval, 1.01-1.74) compared with subjects with the GG genotype. We also observed a potential interaction between genotype and body mass index (BMI) among postmenopausal women, with the highest risk (odds ratio, 2.30; 95% confidence interval, 1.02-5.21) among obese women (BMI >/=30 kg/m(2)) with the GA or AA genotype compared with lean (BMI <25 kg/m(2)) women with the GG genotype. Our findings suggest that the increased production of hPR-B by the +331 G/A polymorphism may predispose women to breast cancer development through increased hPR-B-dependent stimulation of mammary cell growth.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5236-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:14500352-Adult,
pubmed-meshheading:14500352-Alleles,
pubmed-meshheading:14500352-Breast Neoplasms,
pubmed-meshheading:14500352-Case-Control Studies,
pubmed-meshheading:14500352-Female,
pubmed-meshheading:14500352-Genetic Predisposition to Disease,
pubmed-meshheading:14500352-Humans,
pubmed-meshheading:14500352-Middle Aged,
pubmed-meshheading:14500352-Polymorphism, Genetic,
pubmed-meshheading:14500352-Promoter Regions, Genetic,
pubmed-meshheading:14500352-Receptors, Progesterone
|
pubmed:year |
2003
|
pubmed:articleTitle |
A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.
|
pubmed:affiliation |
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. devivo@channing.harvard.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|